These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34189963)

  • 21. Mesenchymal stem cells: Biological characteristics and application in disease therapy.
    Lou S; Duan Y; Nie H; Cui X; Du J; Yao Y
    Biochimie; 2021 Jun; 185():9-21. PubMed ID: 33711361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.
    Lee DK; Song SU
    Cell Immunol; 2018 Apr; 326():68-76. PubMed ID: 28919171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
    Markov A; Thangavelu L; Aravindhan S; Zekiy AO; Jarahian M; Chartrand MS; Pathak Y; Marofi F; Shamlou S; Hassanzadeh A
    Stem Cell Res Ther; 2021 Mar; 12(1):192. PubMed ID: 33736695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
    Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
    Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cell-based therapy.
    Mundra V; Gerling IC; Mahato RI
    Mol Pharm; 2013 Jan; 10(1):77-89. PubMed ID: 23215004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia.
    Liew A; O'Brien T
    Stem Cell Res Ther; 2012 Jul; 3(4):28. PubMed ID: 22846185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulative effects of mesenchymal stem cells derived from human embryonic stem cells in vivo and in vitro.
    Tan Z; Su ZY; Wu RR; Gu B; Liu YK; Zhao XL; Zhang M
    J Zhejiang Univ Sci B; 2011 Jan; 12(1):18-27. PubMed ID: 21194182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cells and immune disorders: from basic science to clinical transition.
    Wang S; Zhu R; Li H; Li J; Han Q; Zhao RC
    Front Med; 2019 Apr; 13(2):138-151. PubMed ID: 30062557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
    Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
    Cells; 2019 May; 8(5):. PubMed ID: 31100966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential.
    Li J; Zhang Q; Wang W; Lin F; Wang S; Zhao J
    J Neurol; 2021 Nov; 268(11):4095-4107. PubMed ID: 32761505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases.
    Guo Y; Yu Y; Hu S; Chen Y; Shen Z
    Cell Death Dis; 2020 May; 11(5):349. PubMed ID: 32393744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells alleviate atherosclerosis by elevating number and function of CD4(+)CD25 (+)FOXP3 (+) regulatory T-cells and inhibiting macrophage foam cell formation.
    Wang ZX; Wang CQ; Li XY; Feng GK; Zhu HL; Ding Y; Jiang XJ
    Mol Cell Biochem; 2015 Feb; 400(1-2):163-72. PubMed ID: 25389006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterospheroid formation improves therapeutic efficacy of mesenchymal stem cells in murine colitis through immunomodulation and epithelial regeneration.
    Regmi S; Seo Y; Ahn JS; Pathak S; Acharya S; Nguyen TT; Yook S; Sung JH; Park JB; Kim JO; Young CS; Kim HS; Jeong JH
    Biomaterials; 2021 Apr; 271():120752. PubMed ID: 33730631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune response.
    Wei X; Sun G; Zhao X; Wu Q; Chen L; Xu Y; Pang X; Qi G
    Int J Mol Med; 2019 Oct; 44(4):1425-1435. PubMed ID: 31364743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives.
    Regmi S; Pathak S; Kim JO; Yong CS; Jeong JH
    Eur J Cell Biol; 2019 Dec; 98(5-8):151041. PubMed ID: 31023504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
    Wang D; Sun YQ; Gao WX; Fan XL; Shi JB; Fu QL
    Cell Transplant; 2018 Sep; 27(9):1340-1351. PubMed ID: 30056763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 Cells.
    Wang LT; Jiang SS; Ting CH; Hsu PJ; Chang CC; Sytwu HK; Liu KJ; Yen BL
    Stem Cells; 2018 Jun; 36(6):903-914. PubMed ID: 29396902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved Isolation of Human Vascular Wall-Resident Mesenchymal Stem Cells.
    Klein D
    Methods Mol Biol; 2020; 2155():71-81. PubMed ID: 32474868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9.
    Fan J; Tang X; Wang Q; Zhang Z; Wu S; Li W; Liu S; Yao G; Chen H; Sun L
    Stem Cell Res Ther; 2018 Sep; 9(1):237. PubMed ID: 30223894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action.
    Shin TH; Kim HS; Choi SW; Kang KS
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28125063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.